Suppr超能文献

在心脏临床前研究中,动作电位实验完成了hERG检测和QT间期测量。

Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies.

作者信息

Ducroq Joffrey, Printemps Richard, Guilbot Stephanie, Gardette Jean, Salvetat Céline, Le Grand Marie

机构信息

PhysioStim, Z.I. de Brénas-Lautrec, 81440 Lautrec, France.

出版信息

J Pharmacol Toxicol Methods. 2007 Sep-Oct;56(2):159-70. doi: 10.1016/j.vascn.2007.03.009. Epub 2007 May 23.

Abstract

INTRODUCTION

The ICHS7B guideline focused on hERG and QT assays, although other factors have also been linked with the induction of severe arrhythmias. Thus, the aim of the present study was to demonstrate that two in vitro action potential recordings constitute convincing models of predictive drug-induced Torsades de pointes (TdP) and re-entry arrhythmias.

METHODS

The effects of D,L-sotalol, flecainide and quinidine were investigated on potassium (hERG) and sodium (Na(V)1.5) currents transfected in HEK-293 cells to determine the repercussion of the blockade of these currents on rabbit Purkinje fibre (PF) and atrial action potentials. Atrial conduction velocity was also investigated as a model of re-entry arrhythmias.

RESULTS

hERG channels were blocked by D,L-sotalol, quinidine and flecainide (IC(50): 69, 0.33 and 0.74 micromol/L, respectively). D,L-sotalol (30 micromol/L) induced reverse-use dependent increases in action potential duration (APD(90): +31.7% and +81.2% at 1 and 0.2 Hz) and triangulation (APD(90-40): +34.7% and +73.6% at 1 and 0.2 Hz) in PF but not in atria. Quinidine (10 micromol/L) also increased APD(90) (+14.5% and +68.5% at 1 and 0.2 Hz) and APD(90-40) (+73.3% and +152.1% at 1 and 0.2 Hz) in PF. Flecainide (10 micromol/L) shortened APD(90) in PF (-26.0% and - 22.2% at 1 and 0.2 Hz). Quinidine and flecainide blocked Na(V)1.5 channels by 32.3% and 73.1%, respectively, and produced decreases in dV/dt(max) which were more marked in atria (-20.4% and -31.9%) compared to PF (-12.8% and 22.4%) at 1 Hz. Finally, quinidine and flecainide decreased atrial conduction speed by 14.6% and 30.8%, respectively.

CONCLUSION

Results obtained with flecainide demonstrate that use of the hERG channel alone should not be considered as a useful single assay. Rabbit Purkinje fiber action potentials can be considered as a comparable model for detection of reverse-use dependent APD prolongation and triangulation whereas the rabbit atria can be considered as a useful model for detection of sodium channel blockade associated with decreases in dV/dt(max) and conduction velocity.

摘要

引言

国际协调会议(ICH)S7B指南聚焦于人类ether-à-go-go相关基因(hERG)和QT检测,尽管其他因素也与严重心律失常的诱发有关。因此,本研究的目的是证明两种体外动作电位记录构成预测药物诱导尖端扭转型室速(TdP)和折返性心律失常的可信模型。

方法

研究了D,L-索他洛尔、氟卡尼和奎尼丁对转染于人类胚胎肾(HEK)-293细胞中的钾离子(hERG)和钠离子(Na(V)1.5)电流的影响,以确定这些电流阻断对兔浦肯野纤维(PF)和心房动作电位的影响。还研究了心房传导速度作为折返性心律失常的模型。

结果

D,L-索他洛尔、奎尼丁和氟卡尼阻断hERG通道(半数抑制浓度(IC(50)):分别为69、0.33和0.74微摩尔/升)。D,L-索他洛尔(30微摩尔/升)在PF中诱导动作电位时程(APD(90):在1赫兹和0.2赫兹时分别增加31.7%和81.2%)和三角化(APD(90 - 40):在1赫兹和0.2赫兹时分别增加34.7%和73.6%)呈反向使用依赖性增加,但在心房中未出现。奎尼丁(10微摩尔/升)也使PF中的APD(90)增加(在1赫兹和0.2赫兹时分别增加14.5%和68.5%)以及APD(90 - 40)增加(在1赫兹和0.2赫兹时分别增加73.3%和152.1%)。氟卡尼(10微摩尔/升)使PF中的APD(90)缩短(在1赫兹和0.2赫兹时分别缩短26.0%和22.2%)。奎尼丁和氟卡尼分别阻断Na(V)1.5通道32.3%和73.1%,并使最大去极化速率(dV/dt(max))降低,在1赫兹时,心房中的降低更明显(分别降低20.4%和31.9%),而PF中降低较少(分别降低12.8%和22.4%)。最后,奎尼丁和氟卡尼分别使心房传导速度降低14.6%和30.8%。

结论

氟卡尼的研究结果表明,仅使用hERG通道不应被视为一种有用的单一检测方法。兔浦肯野纤维动作电位可被视为检测反向使用依赖性APD延长和三角化的可比模型,而兔心房可被视为检测与dV/dt(max)降低和传导速度降低相关的钠通道阻断的有用模型。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验